The 4th Annual Rare and Genetic Kidney Disease Drug Development Summit is dedicated to the development of therapeutic treatments in PKD, IgA, FSGS, Alport Syndrome and more.
Topics
- Applications of microRNA as a treatment for ADPKD, Alport Syndrome, FSGS, IgAN and more
- New diagnostic tools beyond creatinine, proteinuria, and total kidney
- Evidence to achieve FDA’s full approval of a biologic and demonstrate long-term efficacy
- Disease modelling of genetic kidney diseases through stem cell-derived kidney organoids
